Your Advisors
Michael A. Robinson
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance, and Nexus-9 Network.
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance, and Nexus-9 Network.
Michael'S LATEST HEADLINES
-
Here’s My Favorite Facebook Alternative Right Now
Facebook’s currently in the middle of a controversy over the role “Big Tech” should – or shouldn’t – play in regulating speech, with the federal government and some 46 state attorneys general actively seeking the breakup of the world’s most successful social media site.
Playing this space just right can give savvy tech investors double the market’s return….
Read more... - Double Your Money as America Kicks Cable to the Curb
- 2021 Tech Forecast: Invest in These $5.2 Trillion Trends Now
- Profit on Amazon’s Growth at One-Third the Price
- This Tech-Breakthrough Stock Has Tripled the Market’s Returns and Is About to Go Much Higher
- Grow Your Portfolio with This Company That's Saving the Space Sector
- The Smart Way to Buy AAPL and MSFT… and Protect All Your Profits
- A Biden Presidency Should Ignite AVAV and These Two Other Stocks
- The Internet's Heading to Space – and This Stock Will Take Your Portfolio Along for the Profitable Ride
- Don't Buy Google While the Antitrust Heat Is On – Buy This Instead